4//SEC Filing
RESPONSE BIOMEDICAL CORP 4
Accession 0001437749-13-015949
CIK 0000806888operating
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:05 PM ET
Size
8.9 KB
Accession
0001437749-13-015949
Insider Transaction Report
Form 4
HOLLER ANTHONY F
Director
Transactions
- Sale
Common Stock
2012-11-28$1.05/sh−45,500$47,775→ 0 total - Award
Stock Option (Right to Buy)
2013-03-14+20,000→ 40,000 totalExercise: $3.10Exp: 2023-03-14→ Common Stock (20,000 underlying) - Award
Stock Option (Right to Buy)
2012-04-02+20,000→ 20,000 totalExercise: $2.20Exp: 2022-04-02→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Exercise prices shown are denominated in Canadian dollars.
- [F2]100% of the options vest on the one year anniversary of the date of grant.
- [F3]On June 19, 2012, the final voting results of the annual meeting of the Company's shareholders effected a consolidation of the Company's outstanding common shares such that each twenty outstanding common shares will be consolidated into one common share.
Documents
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000806888
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 6:05 PM ET
- Size
- 8.9 KB